about
PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic DrugsDichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cellsHyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.Human PrP90-231-induced cell death is associated with intracellular accumulation of insoluble and protease-resistant macroaggregates and lysosomal dysfunction.Selection of candidate housekeeping genes for normalization in human postmortem brain samples.MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma.Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD.Global profiling of viral and cellular non-coding RNAs in Epstein-Barr virus-induced lymphoblastoid cell lines and released exosome cargos.Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids.Probing cytoskeleton organisation of neuroblastoma cells with single-cell force spectroscopy.Acquisition of neuron-like electrophysiological properties in neuroblastoma cells by controlled expression of NDM29 ncRNA.NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion.Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome.Comparison of Immunosuppressive and Angiogenic Properties of Human Amnion-Derived Mesenchymal Stem Cells between 2D and 3D Culture SystemsLung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profilePIWI-interacting RNA (piRNA) signatures in human cardiac progenitor cellsMicroRNA-mediated Regulation of Mucin-type O-glycosylation Pathway: A Putative Mechanism of Salivary Gland Dysfunction in Sjögren Syndrome
P50
Q28066756-593B28F0-256C-4A65-8B79-692BA0DDEAC8Q28237181-C3EE7CD4-C29A-4B78-A039-C0F8512020E3Q33567866-192B6C8C-C580-4B00-9978-2D70F1C60703Q35006421-54CDA19C-C7A2-434E-BDBE-29C62B88E03CQ35296864-6E057BC9-22AA-45EE-BE23-F35E9096D663Q35922940-12664317-F687-425A-912C-02AB17ACF86BQ36379634-5F8A051D-D8AC-402D-B4A8-06A2EB211130Q37420964-6678B327-CC2A-418C-96BE-069199CA3FDDQ38726562-A9B77E5C-F2B5-4D3E-A0FD-03859A69DFFAQ39295233-26CFB01D-254A-46BD-A270-77D6403BFB7BQ39360123-AB799641-5A7C-41E2-AB02-1845D7D3C3E7Q39471005-38AFDF2F-9176-4A58-B591-B77076C181B5Q43784333-4E98A1C5-EC8D-4DD7-B671-E1112A04ABE6Q51087953-9A1FBA48-E722-4CFB-9441-C55094547F12Q62663470-3A020705-7EA9-4187-B988-5209E2FE1ADAQ62663471-757F3FB6-E0D8-4815-8283-194B8C2777C7Q62663473-B89206C7-021B-489B-9110-7B4E11D0DA4AQ92060982-8C06DF15-49AA-4FEC-8448-2A0C8B40C430
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Serena Vella
@ast
Serena Vella
@en
Serena Vella
@es
Serena Vella
@nl
type
label
Serena Vella
@ast
Serena Vella
@en
Serena Vella
@es
Serena Vella
@nl
prefLabel
Serena Vella
@ast
Serena Vella
@en
Serena Vella
@es
Serena Vella
@nl
P106
P108
P1153
48462224500
P21
P31
P496
0000-0001-9477-9294